Subscribe to MDT Magazine News

Pacira Pharmaceuticals, Inc. Announces EXPARELâ„¢ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting

May 23, 2011 3:34 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., May 23, 2011 /- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that clinical data highlighting the safety profile of EXPAREL™ (bupivacaine extended-release liposome injection) will be presented at the...


Mylan Launches Generic Version of Depakote® Sprinkle Capsules

May 23, 2011 3:34 am | by Bio-Medicine.Org | Comments

PITTSBURGH, May 23, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's Depakote® Sprinkle Capsules, a treatment for certain types of seizures.  ...


Reportlinker Adds Advanced Digital Medical Equipment Products Market

May 23, 2011 3:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 23, 2011 /- announces that a new market research report is available in its catalogue: Advanced Digital Medical Equipment Products Market


PAREXEL International to Present at Goldman Sachs Healthcare Conference and Jefferies Global Healthcare Conference

May 23, 2011 2:34 am | by Bio-Medicine.Org | Comments

BOSTON, May 23, 2011 /- PAREXEL International Corporation (NASDAQ: PRXL ) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at...


Boston Healthcare Acquires Alpha Care GmbH, Expanding Health Economics, Pricing and Reimbursement Consulting Presence in Europe

May 23, 2011 2:32 am | by Bio-Medicine.Org | Comments

BOSTON and BERLIN, May 23, 2011 /- Boston Healthcare announced today that it has acquired Alpha Care GmbH, a consulting firm based in Germany that provides health economics and policy solutions for pharmaceutical, medical device, payer and provider organizations. Through this acquisition,...


Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist

May 23, 2011 2:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 23, 2011 /- Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery , CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year®...


An X Prize for Mobile Diagnostics

May 22, 2011 8:35 pm | by Massachusetts Institute of Technology | Comments

A $10 million prize would go to the first device that can diagnose a range of diseases with the same accuracy as a team of doctors.


A Nightshirt to Monitor Sleep

May 22, 2011 8:33 pm | by Massachusetts Institute of Technology | Comments

A newly developed smart shirt detects the wearer's stage of sleep via respiration patterns.


Chris Horner wraps up Tour of California title

May 22, 2011 4:45 pm | by GREG BEACHAM - AP Sports Writer - Associated Press | Comments

Chris Horner won the Tour of California with a solid performance in the final stage on Sunday, holding off RadioShack teammate Levi Leipheimer by 38 seconds.The 39-year-old Horner was the oldest rider to complete the race, crossing the finish line with both hands thrust into the air near the...

Initiative to promote commercial uptake of microfluidic devices

May 20, 2011 11:43 pm | by I-Micronews | Comments

International microfluidic consortium driving standardization activities for solutions in healthcare, environmental applications, and beyond.

SimplyThick: Public Health Notification - Risk of Life-Threatening Bowel Condition

May 20, 2011 2:30 pm | by U.S. Food & Drug Administration | Comments

Feeding this product to infants may result in necrotizing enterocolitis, a life-threatening condition resulting in necrosis of intestinal tissue.


NRC Suggests Revamp for FDA & #8217;s Risk-Assessment Framework

May 20, 2011 1:48 pm | by U.S. Food & Drug Administration | Comments

The National Research Council (NRC), a nonprofit that provides scientific advice, is suggesting a three-step risk-characterization framework to assist the FDA in making product-related decisions with potential public health consequences.

Device Liability Limiting Bill Passes in House

May 20, 2011 1:48 pm | by U.S. Food & Drug Administration | Comments

A bill that would set limits on device liability suits, and would grant additional protection to 510(k) devices, has passed the U.S. House of Representatives but faces challenges in the Senate.

TSX-listed corporate dividends and distributions declared May 20, 2011

May 20, 2011 11:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on May 20, 2011.Primary Energy Recycling Corporation (TSX:PRI): $0. Payable May 31. Record May 31.Aic Global Financial Split Corp. Pr (TSX:ASC.PR.A): $0.08798. Payable Jun 06. Record...

Biogen MS drug to aid walking nears European approval

May 20, 2011 9:49 am | by Mass High Tech: The Journal of New England Technology | Comments

An oral drug candidate developed by Biogen Idec Inc. and intended to improve walking ability in patients with multiple sclerosis – known in the U.S. as Ampyra – will likely get marketing approval in Europe. The news follows a January report in which the drug got a negative opinion from...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.